FGF21 and Hyperglycemia: Pharmacologic inhibition of 5-HT2BRs ameliorates hyperglycemia associated with alterations of hepatic FGF21 and 5-HT2AR expression and plasma FGF21 levels without affecting food intake and body weight in obese and diabetic mice such as KKAy and db/db mice [99].